METHODS OF USING AND COMPOSITIONS INCLUDING AN INCRETIN ANALOG
Application
US20260091087A1
Kind: A1
Apr 02, 2026
Inventors
Tamer COSKUN, Zvonko MILICEVIC, Shweta URVA
Abstract
Doses and dosing regimens for incretin analogs are disclosed comprising determining and administering doses of long-acting incretin analogs suitable for once-weekly dosing, such as a glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1) and glucagon (GCG) (GGG) tri-receptor agonist.
CPC Classifications
A61K 38/26
A61P 3/04
A61P 3/10
Filing Date
2025-11-18
Application No.
19393199